In silico evaluation of imidazopyridine compounds targeting ACE2: molecular dynamics and binding energy analysis
{{output}}
Angiotensin-converting enzyme 2 (ACE2) regulates cardiovascular function and serves as the SARS-CoV-2 entry receptor, making it a dual therapeutic target. Most drug development focuses on the virus rather than exploring broader host-directed protective strateg... ...
